Baillie Gifford

Baillie Gifford is an independently owned investment management firm. It is owned and run by 39 of its senior executives, who operate as a partnership, a structure that has endured for over a century and provides stability for clients and motivation for employees. It enables them to manage the business for the future as well as the present, with an emphasis on genuine long-term thinking rather than lurching haplessly between short-term targets.

Chris Evdaimon

Investment Manager, Private Companies

Brogan Harris

Investment Manager

Lee Qian

Investment Manager

Tom Slater

Partner

Past deals in Series F

Anduril Industries

Series F in 2024
Anduril Industries is a defense technology company that designs, manufactures, and deploys advanced hardware and software products to address complex national security challenges for the United States and its allies. Founded in 2017 and headquartered in Irvine, California, the company specializes in developing cutting-edge solutions, including the Lattice Platform—an artificial intelligence system that integrates real-time data into a cohesive operational picture—and the Sentry Tower, which consolidates data from various electromagnetic sources. Additionally, Anduril produces the Ghost sUAS, a man-portable unmanned aerial system capable of executing numerous missions autonomously, and the Anvil sUAS, designed for precision interception of drone threats with human operator verification. Through its innovative technologies, Anduril aims to enhance military capabilities and border surveillance, ensuring the safety and effectiveness of those serving in defense of national interests.

HeartFlow

Series F in 2023
HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

Rappi

Series F in 2021
Rappi is a consumer technology company focused on online delivery services across Latin America. It operates an on-demand delivery platform that connects consumers with local merchants and independent couriers. Through its technology and logistical capabilities, Rappi enables users to order a wide variety of items, including prepared foods, groceries, pharmaceuticals, and liquor, all of which can be delivered directly to their homes. The company's services cater to diverse consumer needs, making it a versatile option for those seeking convenience in their shopping experiences.

Warby Parker

Series F in 2020
Warby Parker is a lifestyle brand that designs and develops prescription glasses, contact lenses, and eyewear accessories, while also offering eye exams and vision tests. The company aims to provide high-quality designer eyewear at accessible prices, addressing the critical issue that approximately one billion people lack access to affordable glasses. By partnering with experienced non-profit organizations, Warby Parker ensures that each sale contributes to giving someone in need access to eyewear, which can significantly impact their quality of life and economic opportunities. The company's revenue primarily comes from the sale of eyewear products and optical services, which are available through its retail stores, website, and mobile applications. Warby Parker's commitment to social responsibility is integral to its business model, as it seeks to combine profitability with positive social impact.

Thumbtack

Series F in 2019
Thumbtack, Inc. operates an online marketplace that connects homeowners with skilled professionals across various service sectors. The platform allows users to find and hire service providers for tasks such as moving, plumbing, electrical work, landscaping, and event management, among others. With a network of around 300,000 local service businesses, Thumbtack offers personalized guidance to homeowners, helping them navigate project timelines and make informed hiring decisions. Established in 2008 and headquartered in San Francisco, California, the company aims to simplify home management by enabling users to efficiently manage home-related tasks and improvements.

FlixBus

Series F in 2019
FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.

Tempus

Series F in 2019
Tempus is a technology company improving precision medicine through the practical application of artificial intelligence in healthcare. Their platform is designed to analyze and interpret clinical and molecular data to help healthcare providers deliver more personalized and effective treatments.

Funding Circle

Series F in 2017
Funding Circle Limited operates an online marketplace that connects small and medium-sized businesses seeking loans with individual and institutional investors. Founded in 2009 and based in London, the platform allows various lenders, including individuals, banks, local councils, and financial organizations, to provide unsecured and secured loans for various business needs, such as working capital, asset purchases, and property development. By facilitating direct lending, Funding Circle offers businesses fast access to financing while providing investors with the opportunity to earn attractive returns. The company serves a diverse range of industries, including software, retail, energy, healthcare, construction, e-commerce, and industrial sectors, aiming to foster growth, create jobs, and support local communities.

Ola

Series F in 2015
Ola operates a mobile technology platform that integrates city transportation for customers and driver partners in India. Its mobile application allows its customers to book a range of cabs, auto-rickshaws, bikes, and shuttle buses. Ola's mobile application allows customers to book city taxi, outstation travel, car rental, and corporate travel services. Its mobile application is available on Windows, Android, and iOS platforms. Ankit Bhati and Bhavish Aggarwal founded Ola on December 1, 2010. It has its headquarters with additional offices in Bengaluru in India.

CureVac

Series F in 2015
CureVac is a clinical-stage biopharmaceutical company based in Germany, focused on developing vaccines and therapies utilizing messenger RNA (mRNA). Founded in 2000, the company’s innovative approach involves using mRNA as a data carrier to instruct the body to produce proteins that can combat various diseases. CureVac's pipeline includes novel mRNA-based cancer immunotherapies, prophylactic vaccines for infectious diseases, and molecular therapies aimed at enhancing the body’s production of therapeutic proteins. Its most advanced candidate, CV9104, is currently in Phase IIb clinical trials for prostate cancer treatment. Additionally, CureVac has collaborated with GSK to create second-generation vaccines for seasonal influenza and COVID-19, as well as an avian influenza vaccine, while exploring other mRNA vaccine applications in oncology and various therapeutic areas.

HelloFresh

Series F in 2015
HelloFresh is a food subscription company that delivers personalized meal boxes containing pre-portioned ingredients to customers' doorsteps each week. The company focuses on providing quick and healthy meal solutions designed by nutritionists and chefs, allowing households to enjoy wholesome home-cooked meals without the need for planning or shopping. Operating in multiple international markets, including Europe, Japan, Australia, and North America, HelloFresh aims to revolutionize the way consumers shop for food and prepare meals by simplifying the cooking process. Its subscription model promotes convenience and addresses the desire for high-quality, ecological foods. By fundamentally changing the traditional food supply chain, HelloFresh is positioned at the forefront of the online food delivery trend.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.